Adamas Pharmaceuticals
ADMS
#7340
Rank
ยฃ0.30 B
Marketcap
ยฃ6.61
Share price
0.00%
Change (1 day)
16,692.79%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): ยฃ64.62 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is ยฃ70.94 Million. In 2020 the company made a revenue of ยฃ59.9 Million an increase over the revenue in the year 2019 that were of ยฃ43.95 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ64.62 M7.88%
2020ยฃ59.9 M36.28%
2019ยฃ43.95 M60.48%
2018ยฃ27.38 M
2016ยฃ0.46 M-70.15%
2015ยฃ1.54 M-96.57%
2014ยฃ44.92 M-21.45%
2013ยฃ57.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ65.71 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.52 B 639.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.67 B 62,870.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.38 B 45,543.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ50.82 B 71,534.78%๐Ÿ‡บ๐Ÿ‡ธ USA